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. Types of endocytosis inhibitors, inhibitory pathways, and final concentrations of the inhibitors. Figure S1 . Differential scanning calorimetry (DSC) analysis of the fatty acids -lauric acid (C12), stearic acid (C18), and behenic acid (C22). Glass transition (arrows) was observed in addition to a definite peak corresponding to the melting point in all the thermograms. Figure S2 . Fluorescence spectra of highly concentrated pyrene-modified fatty acids and pyrene (2.5 mM). Excimer emission was observed at 2.5 mM. conjugates, P-C12, P-C18, and P-C22. All the spectra were similar. The intensity of the peak assigned to (CH 2 ) n increased upon changing the conjugated fatty acid from lauric S3 acid (C12) to stearic acid (C18) and behenic acid (C22). Figure S1 . Differential scanning calorimetry (DSC) analysis of the fatty acids -lauric acid, stearic acid, and behenic acid. Glass transition (arrows) was observed in addition to a definite peak corresponding to the melting point in all the thermograms. Figure S2 . Fluorescence spectra of highly concentrated pyrene-modified fatty acids and pyrene (2.5 mM). Excimer emission was observed at 2.5 mM. [ppm] (CH2)n P-C18 S10 Figure S5 . Nuclear magnetic resonance ( 1 H-NMR) spectra of pyrene-fatty acid conjugates, P-C12, P-C18, and P-C22. All the spectra were similar. The intensity of the peak assigned to (CH 2 ) n increased upon changing the conjugated fatty acid from lauric acid (C12) to stearic acid (C18) and behenic acid (C22). [ppm]
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